青光眼是一种破坏视神经的潜在性致盲疾病。
Glaucoma is a potentially blinding illness that damages the optic nerve.
多数青光眼病人是可以治疗的，但是，如果没有及时识别和治疗，青光眼也可以致盲。
If not recognized and treated, glaucoma may cause blindness that could have been prevented in most patients.
亚洲人群屈光不正和青光眼的流行病学特征已经比较明确，但对糖尿病视网膜病变和年龄相关性黄斑变性等重要致盲原因的研究尚有欠缺。
While the epidemiology of refractive errors and glaucoma have been well characterized, there are few population-based knowledge on diabetic retinopathy and age related macular degeneration.
青光眼是当今世界范围内的主要致盲性眼病，严重影响患者的生存质量。
Glaucoma is the main blindness causing disease in the world, which influences patients quality of life (QOL) severely.
还将讨论由沙眼、儿童盲、青光眼及糖尿病致盲的状况。
The situation on blindness by trachoma, childhood blindness, glaucoma, diabeteswill be discussed.
青光眼是一种严重的眼病，在各年龄段人群中都有发生，而且致盲率高，对视力造成的损害是不可逆的。
Glaucoma is a sort of serious eye disease of high probability of causing blind, which might exists in all ages of people, and its damage can not be cured completely.
因此青光眼的早期诊断，早期治疗及其发病机理的研究，对防盲治盲工作有重要意义。
Therefore, to study the mechanism and to explore the methods for early diagnosis and management of glaucoma are of significant importance for prevention and treatment of blindness.
青光眼是世界上第二大致盲眼病，但其发病原因尚不清楚。
It is not yet wholly understood the mechanism of glaucoma, which is the second eye disease leading to blindness.
青光眼是主要的致盲眼病之一，对于该病病因、病理、预防、诊断和治疗的研究都需要青光眼动物模型。
Glaucoma is a leading cause of blindness; We need glaucoma animal model to study the pathogen, pathology, prevention, diagnosis and therapy.
青光眼是全球第二大致盲眼病、不可逆性盲最主要的原因。
Glaucoma has long been recognized as a leading cause of irreversible blindness.
此一每天使用一次之配方预期可以提高治疗顺从性，预防青光眼病患之眼盲。
The once-daily formulation is expected to enhance therapeutic compliance, a key factor for preventing blindness in patients with glaucoma.
此一每天使用一次之配方预期可以提高治疗顺从性，预防青光眼病患之眼盲。
The once-daily formulation is expected to enhance therapeutic compliance, a key factor for preventing blindness in patients with glaucoma.
应用推荐